ClinicalTrials.Veeva

Menu

Efficacy and Tolerance of Formula 609613 37 in Acneic Patients

C

Cosmetique Active

Status

Completed

Conditions

Acne

Treatments

Other: anti-acne face cream and 5% benzoyl peroxide gel
Other: moisturizing cream and 5% benzoyl peroxide gel

Study type

Interventional

Funder types

Industry

Identifiers

NCT05469880
LRP09001-EFFACLAR DUO

Details and patient eligibility

About

Acne affects most adolescents and young adults with varying severity and presentation. For early or localized forms, the first-line treatment is usually local. The available treatments often lead to local irritation, particularly during the first few weeks of use. This is why creams containing exfoliating agents have long been used in acne, as they are considered to allow a faster disappearance of superficial lesions.

The objective of this 6-month double-blind study is to demonstrate in 100 acneic patients the interest of an anti-acne face cream as an adjunct to and in addition to a 5% benzoyl peroxide gel.

Full description

The study is conducted in accordance with the protocol and the legislative and regulatory provisions in force (after obtaining authorization of the French health authorities and the favorable opinion of the ethics committee).

Regarding the statistical analysis, two different analysis are performed:

  • Descriptive analysis: quantitative variables are described by the mean and standard deviation and qualitative variables by the raw number of each modality and the corresponding percentage.
  • Comparative analysis: for quantitative variables, inter-group comparisons are made by a Student's T-test or a non parametric Mann-Whitney test if necessary. For qualitative variables, comparisons are made using a Chi-square test, if the expected number of participants is less than 5, Fischer's exact test on a 4-box contingency tables is used.

A significant level of p <0.05 is considered as significant. A double-data entry is carried out then a comparison of the two databases is performed. Finally internal and external consistency tests are planned. Missing data are described and possibly analyzed.

Enrollment

100 patients

Sex

All

Ages

15 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • acneic facial skin
  • between 20 and 50 non-inflammatory lesions on the face
  • between 10 and 40 superficial inflammatory lesions on the face
  • no local acneic treatment in the previous 15 days
  • no treatment with isotretinoin in the previous 3 months
  • agreeing to apply only the study products

Exclusion criteria

  • less than 20 or more than 50 non-inflammatory lesions on the face
  • less than 10 or more than 40 superficial inflammatory lesions on the face
  • prescription of a local acne treatment for less than 15 days
  • prescription of an antibiotic treatment for less than 1 month
  • prescription of an isotretinoin treatment for less than 3 months
  • changing toiletries and hygiene products regularly

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups

moisturizing cream and 5% benzoyl peroxide gel
Active Comparator group
Description:
Participants apply the 5% benzoyl peroxide gel every evening and the moisturizing cream every morning for 3 months. Then they are divided into 2 groups: one applies the anti-acne face cream every morning for 3 months and the other one the moisturizing cream every morning for 3 months.
Treatment:
Other: moisturizing cream and 5% benzoyl peroxide gel
anti-acne face cream and 5% benzoyl peroxide gel
Experimental group
Description:
Participants apply the 5% benzoyl peroxide gel every other night and the anti-acne face cream every morning for 3 months. Then they are divided into 2 groups: one applies the anti-acne face cream every morning for 3 months and the other one the moisturizing cream every morning for 3 months.
Treatment:
Other: anti-acne face cream and 5% benzoyl peroxide gel

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems